Sverre Helge Torp

Sverre Helge Torp is a Professor at the Norwegian University of Science and Technology (NTNU) in the Department of Clinical and Molecular Medicine, and a Consultant Neuropathologist at St. Olavs Hospital, part of Trondheim University Hospital. His work bridges academic research and clinical practice in pathology.

Research Interests:

• Neurooncology, with a focus on meningioma and glioma biology
• Molecular pathology and immunohistochemical analysis of tumour markers
• Clinicopathological correlations in brain tumour diagnosis/prognosis
• Ultrasound-based drug delivery techniques like Acoustic Cluster Therapy (ACT®)
• Investigation of blood-brain barrier permeability mechanisms

His publications from 2020–2025 emphasize advancements in meningioma molecular profiling, tumour-associated macrophage roles, and imaging innovations for targeted therapy. Key topics include TERT promoter mutations, ErbB receptor expression, and somatostatin analog efficacy.

Dr. Torp has received the Best Teacher Award at NTNU’s Faculty of Medicine (2006) and was repeatedly nominated (2005, 2016–2018). His contributions to teaching excellence were also recognized through the 2007 SINTEF Prize awarded to his department’s pathology course.

Advising & Grants: No formal advisees or grants are explicitly listed in the provided information. His collaborative work involves co-authorship on multiple studies, particularly with Dr. Wenche Sjursen, Dr. Ole Solheim, and Dr. Sofie Eline Tollefsen.

Labs & Teams: Based at Laboratoriesenteret, LS21.209, Øya, Erling Skjalgssons g 1, he contributes to research teams focused on neuro-oncological pathology and medical imaging innovations.